Mira Pharmaceuticals (MIRA) Stock Rockets After Pain Drug Tops Morphine in Trials

TLDR Mira Pharmaceuticals stock jumped 70% after-hours following preclinical data showing oral drug Mira-55 outperformed injected morphine in pain relief and inflammation reduction. The study found Mira-55 fully normalized pain thresholds and reduced swelling through CB2 receptor action, while morphine only partially reduced inflammation. The non-psychotropic marijuana analog targets the $70 billion non-opioid pain market [...]

The post Mira Pharmaceuticals (MIRA) Stock Rockets After Pain Drug Tops Morphine in Trials appeared first on Blockonomi.